Hanchung Medical announced that it participated in Cosme Week Tokyo 2026, held from January 14 to 16, 2026, at Tokyo Big Sight, Japan, where it explored the latest global beauty industry trends and introduced its key products to international customers.

Cosme Week Tokyo is one of Asia’s leading beauty trade exhibitions, attracting prominent beauty companies from Japan as well as across Asia, Europe, and the Americas. The event serves as a comprehensive international platform showcasing innovation and new product developments across the entire beauty industry—from cosmetic ingredients and finished products to beauty devices, aesthetics, and packaging. Through its participation, Hanchung Medical closely examined shifting consumer needs and distribution trends in the Japanese and broader Asian markets, while further strengthening its global network through meetings with various international buyers and partners.

In particular, Hanchung Medical officially launched its new HA filler “Celestella”, packaged with 10 syringes per box, and actively highlighted its features and competitiveness to key clients and buyers at its exhibition booth. Based on its user-friendly application and stable supply capabilities, Celestella received strong interest from local aesthetic industry professionals, confirming its potential to expand Hanchung Medical’s global product portfolio.

A representative of Hanchung Medical stated, “Through Cosme Week Tokyo, we were able to directly experience the rapid changes and growth potential of the Asian beauty market,” adding, “With our differentiated product lineup—including Celestella—and our accumulated overseas network, we will continue to grow as a specialized distribution company connecting the global market with the Korean market.”